Ashwin N. Skelly

Ashwin N. Skelly

Auto-generated profile, based on publicly available information

Ashwin N. Skelly

Department of Medicine, Perelman School of Medicine, University of Pennsylvania

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
TTTakeshi Tanoue
Takeshi Tanoue
SMSatoru Morita
Satoru Morita
DPDamian R. Plichta
Damian R. Plichta
ASAshwin N. Skelly
Ashwin N. Skelly
WSWataru Suda
Wataru Suda
KHKenya Honda
Kenya Honda

29 July 2021 in Nature
Verified
Journal Article
Closed access
YSYuko Sato
Yuko Sato
KAKoji Atarashi
Koji Atarashi
DPDamian R. Plichta
Damian R. Plichta
YAYasumichi Arai
Yasumichi Arai
SSSatoshi Sasajima
Satoshi Sasajima
KHKenya Honda
Kenya Honda

11 March 2019 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
ASAshwin N. Skelly
Ashwin N. Skelly
YSYuko Sato
Yuko Sato
SKSean Kearney
Sean Kearney
KHKenya Honda
Kenya Honda

18 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
MFMunehiro Furuichi
Munehiro Furuichi
TKTakaaki Kawaguchi
Takaaki Kawaguchi
MPMarie-Madlen Pust
Marie-Madlen Pust
KYKeiko Yasuma-Mitobe
Keiko Yasuma-Mitobe
DPDamian R. Plichta
Damian R. Plichta
KHKenya Honda
Kenya Honda
Persistent colonization and outgrowth of potentially pathogenic organisms in the intestine can result from long-term antibiotic use or inflammatory conditions, and may perpetuate dysregulated immunity and tissue damage1,2. Gram-negative Enterobacteriaceae gut pathobionts are particularly recalcitrant to conventional antibiotic treatment3,4, although an emerging body of evidence suggests that manipulation of the commensal microbiota may be a practical alternative therapeutic strategy5–7. Here we isolated and down-selected commensal bacterial consortia from stool samples from healthy humans that could strongly and specifically suppress intestinal Enterobacteriaceae. One of the elaborated consortia, comprising 18 commensal strains, effectively controlled ecological niches by regulating gluconate availability, thereby re-establishing colonization resistance and alleviating Klebsiella- and Escherichia-driven intestinal inflammation in mice. Harnessing these activities in the form of live bacterial therapies may represent a promising solution to combat the growing threat of proinflammatory, antimicrobial-resistant Enterobacteriaceae infection.

21 September 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MPMark M. Painter
Mark M. Painter
TJTimothy S. Johnston
Timothy S. Johnston
KLKendall A. Lundgreen
Kendall A. Lundgreen
JSJefferson Santos
Jefferson Santos
JQJuliana Qin
Juliana Qin
EWE. John Wherry
E. John Wherry

26 June 2017 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
JHJason E. Hudak
Jason E. Hudak
DADavid Alvarez
David Alvarez
ASAshwin Skelly
Ashwin Skelly
UAUlrich H. von Andrian
Ulrich H. von Andrian
DKDennis L. Kasper
Dennis L. Kasper
The immunomodulatory surface molecules of commensal and pathogenic bacteria are critical to microorganisms' survival and the host's response1,2. Recent studies have highlighted the unique and important responses elicited by commensal-derived surface macromolecules3–5. However, the technology available to track these molecules in host cells and tissues remains primitive. We report, here, an interdisciplinary approach that uses metabolic labelling combined with bioorthogonal click chemistry (that is, reactions performed in living organisms)6 to specifically tag up to three prominent surface immunomodulatory macromolecules—peptidoglycan, lipopolysaccharide and capsular polysaccharide—either simultaneously or individually in live anaerobic commensal bacteria. Importantly, the peptidoglycan labelling enables, for the first time, the specific labelling of live endogenous, anaerobic bacteria within the mammalian host. This approach has allowed us to image and track the path of labelled surface molecules from live, luminal bacteria into specific intestinal immune cells in the living murine host during health and disease. The chemical labelling of three specific macromolecules within a live organism offers the potential for in-depth visualization of host–pathogen interactions.